| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Scynexis Inc (SCYX) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. SCYX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 853.1K | $816.7K | - | |
| Dir | 78.0K | $74.7K | - | |
| Dir | 74.0K | $70.8K | - | |
| Dir | 70.0K | $67.0K | - | |
| Dir | 69.6K | $66.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | Anido Armando | Director | Buy | 5,000 | $6.25 | $31,250.00 | New | |
| Dec 21, 2020 | Gilman Steven C70 | Director | Buy | 4,000 | $6.25 | $25,000.00 | New | |
| Dec 21, 2020 | MacDonald Guy | Director | Buy | 8,000 | $6.25 | $50,000.00 | +200.0% | |
| Dec 12, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 166,667 | $0.90 | $150,000.30 | +31.6% | |
| Aug 21, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $1.11 | $11,100.00 | +1.0% | |
| Aug 15, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 10,015 | $1.01 | $10,115.15 | +2.0% | |
| Apr 17, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.63 | $40,750.00 | +5.2% | |
| Jan 10, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $0.69 | $17,250.00 | +5.5% | |
| Dec 31, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $0.46 | $11,500.00 | +5.8% | |
| Dec 31, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 12,000 | $0.50 | $5,950.80 | +10.9% |